Biohaven Pharmaceutical Holding Stock Price on October 23, 2024
| BHVN Stock | USD 46.01 0.37 0.80% |
If you're considering investing in Biohaven Stock, it is important to understand the factors that can impact its price. As of today, the current price of Biohaven Pharmaceutical stands at 46.01, as last reported on the 29th of November, with the highest price reaching 47.31 and the lowest price hitting 45.96 during the day. Biohaven Pharmaceutical appears to be very steady, given 3 months investment horizon. Biohaven Pharmaceutical secures Sharpe Ratio (or Efficiency) of 0.1, which signifies that the company had a 0.1% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Biohaven Pharmaceutical Holding, which you can use to evaluate the volatility of the firm. Please makes use of Biohaven Pharmaceutical's Mean Deviation of 2.47, risk adjusted performance of 0.0586, and Downside Deviation of 2.56 to double-check if our risk estimates are consistent with your expectations.
At this time, Biohaven Pharmaceutical's Total Stockholder Equity is very stable compared to the past year. As of the 29th of November 2024, Other Stockholder Equity is likely to grow to about 73.8 M, while Common Stock Shares Outstanding is likely to drop about 53.5 M. . At this time, Biohaven Pharmaceutical's Price Book Value Ratio is very stable compared to the past year. As of the 29th of November 2024, Price Earnings To Growth Ratio is likely to grow to 0.14, while Price To Sales Ratio is likely to drop 0.46. Biohaven Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Biohaven |
Sharpe Ratio = 0.1043
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BHVN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.54 actual daily | 31 69% of assets are more volatile |
Expected Return
| 0.37 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 8 92% of assets perform better |
Based on monthly moving average Biohaven Pharmaceutical is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biohaven Pharmaceutical by adding it to a well-diversified portfolio.
Price Book 14.8416 | Book Value 3.33 | Enterprise Value 4.3 B | Enterprise Value Ebitda (2.19) | Shares Float 84.2 M |
Related Headline
Inhibrx Headline on 23rd of October 2024
Disposition of 15000 shares by Kayyem Jon Faiz of Inhibrx at... by Kayyem Jon Faiz
Filed transaction by Inhibrx Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Biohaven Pharmaceutical Valuation on October 23, 2024
It is possible to determine the worth of Biohaven Pharmaceutical on a given historical date. On October 23, 2024 Biohaven was worth 52.38 at the beginning of the trading date compared to the closed value of 52.75. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Biohaven Pharmaceutical stock. Still, in general, we apply an absolute valuation method to find Biohaven Pharmaceutical's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Biohaven Pharmaceutical where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Biohaven Pharmaceutical's related companies.
| Open | High | Low | Close | Volume | |
| 50.67 | 52.81 | 50.58 | 52.65 | 466,645 | |
10/23/2024 | 52.38 | 53.35 | 51.70 | 52.75 | 851,994 |
| 53.04 | 54.75 | 51.75 | 52.36 | 502,431 |
| Backtest Biohaven Pharmaceutical | | | Biohaven Pharmaceutical History | | | Biohaven Pharmaceutical Valuation | Previous | Next |
Biohaven Pharmaceutical Trading Date Momentum on October 23, 2024
| On October 24 2024 Biohaven Pharmaceutical Holding was traded for 52.36 at the closing time. The top price for the day was 54.75 and the lowest listed price was 51.75 . The trading volume for the day was 502.4 K. The trading history from October 24, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.74% . The overall trading delta against the current closing price is 4.49% . |
Biohaven Pharmaceutical Fundamentals Correlations and Trends
By evaluating Biohaven Pharmaceutical's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Biohaven Pharmaceutical's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Biohaven financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Biohaven Pharmaceutical Stock history
Biohaven Pharmaceutical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Biohaven is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Biohaven Pharmaceutical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Biohaven Pharmaceutical stock prices may prove useful in developing a viable investing in Biohaven Pharmaceutical
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 71.2 M | 53.5 M | |
| Net Loss | -513.3 M | -538.9 M |
Biohaven Pharmaceutical Quarterly Net Working Capital |
|
Biohaven Pharmaceutical Stock Technical Analysis
Biohaven Pharmaceutical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Biohaven Pharmaceutical Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Biohaven Pharmaceutical Holding cannot be verified against its exchange. Please verify the symbol is currently traded on New York Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Biohaven Pharmaceutical November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Biohaven Pharmaceutical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biohaven Pharmaceutical shares will generate the highest return on investment. By undertsting and applying Biohaven Pharmaceutical stock market strength indicators, traders can identify Biohaven Pharmaceutical Holding entry and exit signals to maximize returns
Biohaven Pharmaceutical Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Biohaven Pharmaceutical's price direction in advance. Along with the technical and fundamental analysis of Biohaven Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Biohaven to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0586 | |||
| Jensen Alpha | 0.1163 | |||
| Total Risk Alpha | (0.31) | |||
| Sortino Ratio | 0.0421 | |||
| Treynor Ratio | 0.241 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biohaven Pharmaceutical Holding. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biohaven Pharmaceutical. If investors know Biohaven will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biohaven Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.37) | Return On Assets (1.19) | Return On Equity (2.65) |
The market value of Biohaven Pharmaceutical is measured differently than its book value, which is the value of Biohaven that is recorded on the company's balance sheet. Investors also form their own opinion of Biohaven Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Biohaven Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biohaven Pharmaceutical's market value can be influenced by many factors that don't directly affect Biohaven Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biohaven Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biohaven Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biohaven Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.